These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 32635388)
1. Methylation in Paço A; de Bessa Garcia SA; Freitas R Cells; 2020 Jul; 9(7):. PubMed ID: 32635388 [No Abstract] [Full Text] [Related]
2. Epigenetic Targets and their Inhibitors in Cancer Therapy. Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
5. Reversing aberrant methylation patterns in cancer. Poke FS; Qadi A; Holloway AF Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939 [TBL] [Abstract][Full Text] [Related]
6. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Morera L; Lübbert M; Jung M Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667 [TBL] [Abstract][Full Text] [Related]
7. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics. Duan YT; Sangani CB; Liu W; Soni KV; Yao Y Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992 [TBL] [Abstract][Full Text] [Related]
8. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer. Hosseini A; Minucci S Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic cancer therapy: Proof of concept and remaining challenges. Mund C; Lyko F Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865 [TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge. Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760 [TBL] [Abstract][Full Text] [Related]
14. Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery. Li Y; Yang G; Yang C; Tang P; Chen J; Zhang J; Liu J; Ouyang L J Med Chem; 2021 Aug; 64(16):11798-11815. PubMed ID: 34378389 [TBL] [Abstract][Full Text] [Related]
15. The epigenome as a target for cancer chemoprevention. Kopelovich L; Crowell JA; Fay JR J Natl Cancer Inst; 2003 Dec; 95(23):1747-57. PubMed ID: 14652236 [TBL] [Abstract][Full Text] [Related]
16. Targeting Chromatin Remodeling for Cancer Therapy. Kaur J; Daoud A; Eblen ST Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757 [TBL] [Abstract][Full Text] [Related]
17. Compendium of aberrant DNA methylation and histone modifications in cancer. Hattori N; Ushijima T Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808 [TBL] [Abstract][Full Text] [Related]
18. Abnormal level of CUL4B-mediated histone H2A ubiquitination causes disruptive HOX gene expression. Lin Y; Yu J; Wu J; Wang S; Zhang T Epigenetics Chromatin; 2019 Apr; 12(1):22. PubMed ID: 30992047 [TBL] [Abstract][Full Text] [Related]
19. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy. Takeshima H; Wakabayashi M; Hattori N; Yamashita S; Ushijima T Carcinogenesis; 2015 Feb; 36(2):192-201. PubMed ID: 25477340 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Herranz M; Esteller M Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]